These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 17176317)
1. Outcomes of 122 diverse adult and pediatric cord blood transplant recipients from a large cord blood bank. Ballen KK; Haley NR; Kurtzberg J; Lane TA; Lindgren BR; Miller JP; Newman B; McCullough J Transfusion; 2006 Dec; 46(12):2063-70. PubMed ID: 17176317 [TBL] [Abstract][Full Text] [Related]
2. Unrelated cord blood transplant experience by the pediatric blood and marrow transplant consortium. Yu LC; Wall DA; Sandler E; Chan KW; Grayson G; Kletzel M Pediatr Hematol Oncol; 2001 Jun; 18(4):235-45. PubMed ID: 11400647 [TBL] [Abstract][Full Text] [Related]
3. Outcome of cord-blood transplantation from related and unrelated donors. Eurocord Transplant Group and the European Blood and Marrow Transplantation Group. Gluckman E; Rocha V; Boyer-Chammard A; Locatelli F; Arcese W; Pasquini R; Ortega J; Souillet G; Ferreira E; Laporte JP; Fernandez M; Chastang C N Engl J Med; 1997 Aug; 337(6):373-81. PubMed ID: 9241126 [TBL] [Abstract][Full Text] [Related]
4. Unrelated umbilical cord blood transplantation for adults with haematological malignancies: results from a single Australian centre. Bradstock KF; Hertzberg MS; Kerridge IH; Svennilson J; McGurgan M; Huang G; Antonenas V; Gottlieb DJ Intern Med J; 2006 Jun; 36(6):355-61. PubMed ID: 16732860 [TBL] [Abstract][Full Text] [Related]
5. Single versus double unrelated umbilical cord blood units for allogeneic transplantation in adults with advanced haematological malignancies: a retrospective comparison of outcomes. Bradstock K; Hertzberg M; Kerridge I; Svennilson J; George B; McGurgan M; Huang G; Antonenas V; Gottlieb D Intern Med J; 2009 Nov; 39(11):744-51. PubMed ID: 19220530 [TBL] [Abstract][Full Text] [Related]
6. Results of the cord blood transplantation study (COBLT): outcomes of unrelated donor umbilical cord blood transplantation in pediatric patients with lysosomal and peroxisomal storage diseases. Martin PL; Carter SL; Kernan NA; Sahdev I; Wall D; Pietryga D; Wagner JE; Kurtzberg J Biol Blood Marrow Transplant; 2006 Feb; 12(2):184-94. PubMed ID: 16443516 [TBL] [Abstract][Full Text] [Related]
8. Cord blood transplant in childhood ALL. Sawczyn KK; Quinones R; Malcolm J; Foreman N; Garrington T; Gore L; Gao D; Giller R Pediatr Blood Cancer; 2005 Dec; 45(7):964-70. PubMed ID: 15929135 [TBL] [Abstract][Full Text] [Related]
9. Outcome following unrelated cord blood transplant in 136 patients with malignant and non-malignant diseases: a report from the Australian and New Zealand children's haematology and oncology group. Petterson TE; Gabriel M; Tiedemann K; Teague L; Shaw PJ; Baker D; Bolton-Jones R; Tapp H; Oswald C; Vowels MR; O'Brien TA Bone Marrow Transplant; 2009 Feb; 43(3):207-15. PubMed ID: 18806837 [TBL] [Abstract][Full Text] [Related]
10. Analysis of risk factors for outcomes after unrelated cord blood transplantation in adults with lymphoid malignancies: a study by the Eurocord-Netcord and lymphoma working party of the European group for blood and marrow transplantation. Rodrigues CA; Sanz G; Brunstein CG; Sanz J; Wagner JE; Renaud M; de Lima M; Cairo MS; Fürst S; Rio B; Dalley C; Carreras E; Harousseau JL; Mohty M; Taveira D; Dreger P; Sureda A; Gluckman E; Rocha V J Clin Oncol; 2009 Jan; 27(2):256-63. PubMed ID: 19064984 [TBL] [Abstract][Full Text] [Related]
11. Clinical outcomes of unrelated donor umbilical cord blood transplantation for 30 adults with hematological malignancies. Kobayashi K; Maeda Y; Hara Y; Nishie-Kataoka M; Nishimori H; Sugiyama H; Namba N; Kubonishi S; Niiya M; Shinagawa K; Ikeda K; Tanimoto M Anticancer Res; 2009 May; 29(5):1763-70. PubMed ID: 19443401 [TBL] [Abstract][Full Text] [Related]
12. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning. Petersen SL Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527 [TBL] [Abstract][Full Text] [Related]
13. Unrelated cord blood transplantation in pediatric patients: a report from Saudi Arabia. Ayas M; Al-Seraihi A; Al-Jefri A; Al-Ahmari A; Al-Mahr M; Al-Ghonaium A; Al-Muhsen S; Al-Mousa H; Al-Dhekri H; Alsaud B; Eldali A; Mohamad A; Al-Humaidan H; Chadrawi A; Al-Kaff M; Al-Hassnan Z; El-Solh H Bone Marrow Transplant; 2010 Aug; 45(8):1281-6. PubMed ID: 20010867 [TBL] [Abstract][Full Text] [Related]
14. Tacrolimus and methotrexate for the prophylaxis of graft-versus-host disease after unrelated donor cord blood transplantation for adult patients with hematologic malignancies. Mori T; Aisa Y; Nakazato T; Yamazaki R; Shimizu T; Mihara A; Yamane A; Ikeda Y; Okamoto S Transplant Proc; 2007 Jun; 39(5):1615-9. PubMed ID: 17580201 [TBL] [Abstract][Full Text] [Related]
15. Tacrolimus as prophylaxis for acute graft-versus-host disease in reduced intensity cord blood transplantation for adult patients with advanced hematologic diseases. Miyakoshi S; Kami M; Tanimoto T; Yamaguchi T; Narimatsu H; Kusumi E; Matsumura T; Takagi S; Kato D; Kishi Y; Murashige N; Yuji K; Uchida N; Masuoka K; Wake A; Taniguchi S Transplantation; 2007 Aug; 84(3):316-22. PubMed ID: 17700155 [TBL] [Abstract][Full Text] [Related]
16. Allogeneic stem cell transplantation for adults with myelodysplastic syndromes: importance of pretransplant disease burden. Warlick ED; Cioc A; Defor T; Dolan M; Weisdorf D Biol Blood Marrow Transplant; 2009 Jan; 15(1):30-8. PubMed ID: 19135940 [TBL] [Abstract][Full Text] [Related]
17. Immunosuppressive total lymphoid irradiation-based reconditioning regimens enable engraftment after graft rejection or graft failure in patients treated with allogeneic hematopoietic stem cell transplantation. Heinzelmann F; Lang PJ; Ottinger H; Faul C; Bethge W; Handgretinger R; Bamberg M; Belka C Int J Radiat Oncol Biol Phys; 2008 Feb; 70(2):523-8. PubMed ID: 17869449 [TBL] [Abstract][Full Text] [Related]
18. Unrelated cord blood and mismatched unrelated volunteer donor transplants, two alternatives in patients who lack an HLA-identical donor. Ringdén O; Okas M; Uhlin M; Uzunel M; Remberger M; Mattsson J Bone Marrow Transplant; 2008 Nov; 42(10):643-8. PubMed ID: 18762760 [TBL] [Abstract][Full Text] [Related]
19. [Allogeneic hematopoietic stem cell transplantation in patients with chronic myeloid leukemia in the Czech Republic--a retrospective analysis of results in years 1988-2005]. Faber E; Koza V; Vítek A; Mayer J; Sedlácek P; Zák P; Zapletalová J; Benesová K; Krejcová H; Steinerová K; Maresová I; Cetkovský P Vnitr Lek; 2006 Dec; 52(12):1172-80. PubMed ID: 17299910 [TBL] [Abstract][Full Text] [Related]
20. Excellent outcome of allogeneic hematopoietic stem cell transplantation using a conditioning regimen with medium-dose VP-16, cyclophosphamide and total-body irradiation for adult patients with acute lymphoblastic leukemia. Shigematsu A; Kondo T; Yamamoto S; Sugita J; Onozawa M; Kahata K; Endo T; Shiratori S; Ota S; Obara M; Wakasa K; Takahata M; Takeda Y; Tanaka J; Hashino S; Nishio M; Koike T; Asaka M; Imamura M Biol Blood Marrow Transplant; 2008 May; 14(5):568-75. PubMed ID: 18410899 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]